{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,17]],"date-time":"2026-05-17T12:20:47Z","timestamp":1779020447339,"version":"3.51.4"},"reference-count":54,"publisher":"Informa UK Limited","issue":"1","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Pharm. Pat. Anal."],"published-print":{"date-parts":[[2015,1]]},"DOI":"10.4155\/ppa.14.53","type":"journal-article","created":{"date-parts":[[2015,1,7]],"date-time":"2015-01-07T15:08:56Z","timestamp":1420643336000},"page":"29-36","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":17,"title":["Oral insulin-delivery System for Diabetes Mellitus"],"prefix":"10.1080","volume":"4","author":[{"given":"Minakshi","family":"Kanzarkar","sequence":"first","affiliation":[{"name":"Nanobiz LLC & Cocreate Consulting Pvt. Ltd.3322 US Hwy 22 West Suite 421 Branchburg\rNJ\r08876\rUSA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Prem Prakash","family":"Pathak","sequence":"additional","affiliation":[{"name":"Nanobiz LLC & Cocreate Consulting Pvt. Ltd.3322 US Hwy 22 West Suite 421 Branchburg\rNJ\r08876\rUSA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mandar","family":"Vaidya","sequence":"additional","affiliation":[{"name":"Nanobiz LLC & Cocreate Consulting Pvt. Ltd.3322 US Hwy 22 West Suite 421 Branchburg\rNJ\r08876\rUSA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles","family":"Brumlik","sequence":"additional","affiliation":[{"name":"Nanobiz LLC & Cocreate Consulting Pvt. Ltd.3322 US Hwy 22 West Suite 421 Branchburg\rNJ\r08876\rUSA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abhishek","family":"Choudhury","sequence":"additional","affiliation":[{"name":"Nanobiz LLC & Cocreate Consulting Pvt. Ltd.3322 US Hwy 22 West Suite 421 Branchburg\rNJ\r08876\rUSA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2015,1,7]]},"reference":[{"key":"e_1_3_2_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2010.01.026"},{"key":"e_1_3_2_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2013.11.002"},{"key":"e_1_3_2_5_1","doi-asserted-by":"publisher","DOI":"10.2337\/diaclin.30.4.138"},{"key":"e_1_3_2_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.reactfunctpolym.2010.10.002"},{"key":"e_1_3_2_7_1","doi-asserted-by":"publisher","DOI":"10.4103\/0250-474X.42968"},{"key":"e_1_3_2_8_1","doi-asserted-by":"publisher","DOI":"10.1177\/193229681300700228"},{"issue":"6","key":"e_1_3_2_9_1","first-page":"1717","article-title":"Newer strategies for insulin delivery","volume":"2","author":"Yogendraji KA","year":"2011","unstructured":"Yogendraji KA Lokwani P Singh N . Newer strategies for insulin delivery. Int. J. Res. Ayurveda Pharm.2 (6), 1717\u20131721 (2011).","journal-title":"Int. J. Res. Ayurveda Pharm."},{"key":"e_1_3_2_10_1","unstructured":"Marina Biotech Inc . US20120094903 (2012)."},{"key":"e_1_3_2_11_1","doi-asserted-by":"crossref","unstructured":"Novo Nordisk . US20080099011 (2008).","DOI":"10.3833\/pdr.v2008i93.213"},{"key":"e_1_3_2_12_1","unstructured":"Oramed Pharmaceuticals Inc . WO2008132731 (2010)."},{"key":"e_1_3_2_13_1","unstructured":"Viacyte Inc . US20140257515 (2014)."},{"key":"e_1_3_2_14_1","unstructured":"Insugen LLC . US8119120 (2012)."},{"key":"e_1_3_2_15_1","unstructured":"Shire Human Genetic Therapies Inc . US20100143314 (2010)."},{"key":"e_1_3_2_16_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrd836"},{"issue":"4","key":"e_1_3_2_17_1","first-page":"144","article-title":"Nanotechnology based oral delivery of insulin \u2013 a retrospect","volume":"2","author":"Balsubramanian J","year":"2013","unstructured":"Balsubramanian J Narayanan N Mohan V Bindu MS . Nanotechnology based oral delivery of insulin \u2013 a retrospect. Int. J. Res. Ayurveda Pharm.2 (4), 144\u2013150 (2013).","journal-title":"Int. J. Res. Ayurveda Pharm."},{"key":"e_1_3_2_18_1","unstructured":"Universidade de Coimbra . EP2120894 (2009)."},{"key":"e_1_3_2_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2012.11.005"},{"key":"e_1_3_2_20_1","doi-asserted-by":"publisher","DOI":"10.1517\/17425247.5.4.403"},{"key":"e_1_3_2_21_1","unstructured":"Reliance Life Science Pvt Ltd . WO2010113176 (2010)."},{"key":"e_1_3_2_22_1","doi-asserted-by":"publisher","DOI":"10.3109\/02652048.2011.576782"},{"key":"e_1_3_2_23_1","unstructured":"Reliance Life Science Pvt Ltd : WO2010113177 (2010)."},{"key":"e_1_3_2_24_1","doi-asserted-by":"publisher","DOI":"10.3109\/03639045.2011.552908"},{"key":"e_1_3_2_25_1","unstructured":"Smolko EE . US8414923 (2013)."},{"key":"e_1_3_2_26_1","unstructured":"Oramed Ltd . EP2279244 (2011)."},{"key":"e_1_3_2_27_1","unstructured":"Inserm Institut . US20140011739 (2014)."},{"key":"e_1_3_2_28_1","unstructured":"Novo Nordisk . US20120071402 (2012)."},{"key":"e_1_3_2_29_1","unstructured":"Bennis F . US8309123 (2012)."},{"key":"e_1_3_2_30_1","unstructured":"Novo Nordisk . WO2009133099 (2009)."},{"key":"e_1_3_2_31_1","unstructured":"SDG Inc. (an Ohio Corporation) . US20090087479 (2010)."},{"key":"e_1_3_2_32_1","unstructured":"Fan S . WO2013040784 (2013)."},{"key":"e_1_3_2_33_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF02867128"},{"issue":"1","key":"e_1_3_2_34_1","first-page":"24","article-title":"Insulin oral delivery may be possible","volume":"1","author":"Singh S","year":"2010","unstructured":"Singh S Patel D Patel NR et al. Insulin oral delivery may be possible. Int. J. Pharma Prof. Res.1 (1), 24\u201351 (2010).","journal-title":"Int. J. Pharma Prof. Res."},{"issue":"3","key":"e_1_3_2_35_1","first-page":"778","article-title":"Commercial challenges and emerging trends in oral delivery of peptide and protein drugs: A review","volume":"2","author":"Sharma A","year":"2011","unstructured":"Sharma A Arora S . Commercial challenges and emerging trends in oral delivery of peptide and protein drugs: A review. Res. J. Pharm. Biol. Chem. Sci.2 (3), 778\u2013790 (2011).","journal-title":"Res. J. Pharm. Biol. Chem. Sci."},{"key":"e_1_3_2_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2007.12.014"},{"issue":"2","key":"e_1_3_2_37_1","first-page":"15","article-title":"Long-awaited dream of oral insulin: where did we reach?","volume":"4","author":"Madhav M","year":"2011","unstructured":"Madhav M . Long-awaited dream of oral insulin: where did we reach?Asian J. Pharm. Clin. Res.4 (2), 15\u201320 (2011).","journal-title":"Asian J. Pharm. Clin. Res."},{"issue":"6","key":"e_1_3_2_38_1","first-page":"34","article-title":"Permeability Enhancement techniques for poorly permeable drugs: a review","volume":"2","author":"Shaikh MS","year":"2012","unstructured":"Shaikh MS Nikita D Derle D Bhamber R . Permeability Enhancement techniques for poorly permeable drugs: a review. J. Appl. Pharm. Sci.2 (6) 34\u201339 (2012).","journal-title":"J. Appl. Pharm. Sci."},{"key":"e_1_3_2_39_1","unstructured":"Council of Scientific and Industrial Research . US20090098205 (2009)."},{"key":"e_1_3_2_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.nano.2014.02.014"},{"key":"e_1_3_2_41_1","unstructured":"Alba Therapeutics Corp . EP1993356 (2008)."},{"key":"e_1_3_2_42_1","unstructured":"Novo Nordisk . US20140056953 (2014)."},{"key":"e_1_3_2_43_1","doi-asserted-by":"crossref","unstructured":"Emisphere Technologies Inc . US7429564 (2008).","DOI":"10.1016\/S1365-6937(08)70052-2"},{"key":"e_1_3_2_44_1","doi-asserted-by":"crossref","unstructured":"Emisphere Technologies Inc . US20100151009 (2010).","DOI":"10.1016\/S1365-6937(10)70145-3"},{"key":"e_1_3_2_45_1","unstructured":"GP Medical Inc . US8361439 (2013)."},{"key":"e_1_3_2_46_1","doi-asserted-by":"publisher","DOI":"10.2147\/IJN.S59075"},{"key":"e_1_3_2_47_1","unstructured":"Nano and Advanced Material Institute . US20130034589 (2013)."},{"key":"e_1_3_2_48_1","unstructured":"Oshadi Drug Administration Ltd . US20100278922 (2010)."},{"key":"e_1_3_2_49_1","unstructured":"Syracuse University . US20110092416 (2011)."},{"key":"e_1_3_2_50_1","unstructured":"Biocon Ltd . US8563685 (2013)."},{"key":"e_1_3_2_51_1","doi-asserted-by":"publisher","DOI":"10.1002\/bies.200800210"},{"key":"e_1_3_2_52_1","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(85)90334-4"},{"key":"e_1_3_2_53_1","doi-asserted-by":"publisher","DOI":"10.1210\/en.2011-1843"},{"key":"e_1_3_2_54_1","unstructured":"Bio Ethic . US7780990 (2010)."},{"key":"e_1_3_2_55_1","unstructured":"Novo Nordisk . EP2523655 (2012)."},{"key":"e_1_3_2_56_1","unstructured":"Novo Nordisk . EP2627670 (2013)."}],"container-title":["Pharmaceutical Patent Analyst"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.4155\/ppa.14.53","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,17]],"date-time":"2024-05-17T14:54:52Z","timestamp":1715957692000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.4155\/ppa.14.53"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1]]},"references-count":54,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,1]]}},"alternative-id":["10.4155\/ppa.14.53"],"URL":"https:\/\/doi.org\/10.4155\/ppa.14.53","relation":{},"ISSN":["2046-8954","2046-8962"],"issn-type":[{"value":"2046-8954","type":"print"},{"value":"2046-8962","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,1]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ippa20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ippa20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2015-01-07","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}